I’m sorry, but I don’t have any reliable information on a drug called Xolremdi. It may be a brand name that isn’t widely reported in the literature, an investigational agent, or a typo for another medication. Could you please double‑check the spelling or provide any additional context (e.g., therapeutic class, indication, country of approval)? With … Read more
Xolair Xolair (omalizumab) is a recombinant humanized IgG1k monoclonal antibody that selectively binds circulating IgE, preventing its interaction with high‑ and low‑affinity FcεRI receptors on mast cells and basophils. It is approved for moderate‑to‑severe persistent allergic asthma and chronic spontaneous urticaria, and is off‑label used for atopic dermatitis, eosinophilic granulomatosis with polyangiitis, and other IgE‑mediated … Read more
Xofluza Xofluza (baloxavir marboxil) is a single‑dose, oral influenza antiviral that markedly shortens time to symptom resolution in uncomplicated influenza viruses. Mechanism of Action Cap‑dependent RNA endonuclease inhibition: – Baloxavir acid (active metabolite) binds to the active site of the influenza polymerase cap‑binding enzyme, blocking cleavage of host mRNA caps needed for viral mRNA synthesis. … Read more
Xofigo > Xofigo (radium‑223 dichloride) is an α‑emitting radiopharmaceutical approved for treatment of bone‑predominant metastases in castration‑resistant prostate cancer (CRPC). Mechanism of Action Radial mimicry of calcium: Radium‑223 substitutes for calcium at bone‑mineralization sites, concentrating in osteoblastic lesions. High‑energy α‑particles: Emit two ~5.5 MeV α‑particles that induce double‑strand DNA breaks within a 10–100 µm radius, selectively killing … Read more
Xiidra Mechanism of Action Cyclosporine A (0.05 %)—a lipid-soluble cyclosporine derivative formulated as a 5 % vehicle–termed or in a micro‑emulsion. Inhibits T‑cell activation by forming a complex with cyclophilin, thereby blocking calcineurin and preventing transcription of pro‑inflammatory cytokines (IL‑2, IFN‑γ, TNF‑α). Decreases ocular surface inflammation, restores tear film stability, and promotes conjunctival goblet‑cell density. Secondary neuroprotective … Read more
Xigduo XR Xigduo XR (dapagliflozin 5–10 mg + metformin extended‑release 500–1000 mg) is an oral combination tablet approved for the treatment of type 2 diabetes mellitus (T2DM). It delivers dual antidiabetic activity through SGLT‑2 inhibition and metformin’s hepatic glucose‑lowering effects. — Mechanism of Action Dapagliflozin: Inhibits the sodium‑glucose co‑transporter‑2 in the proximal renal tubule, reducing glucose reabsorption (~180 g/day) and … Read more
Xifaxan Xifaxan (rifaximin) is a non‑absorbable oral antibiotic that selectively targets gastrointestinal pathogens, making it a cornerstone for treating functional gastrointestinal disorders and enteric infections. Mechanism of Action Selective ribosomal binding: Rifaximin binds to the β‑subunit of bacterial DNA‑dependent RNA polymerase, inhibiting transcription of essential bacterial genes. Minimal systemic absorption: < 0.4 % bioavailability ensures the drug … Read more
Xiaflex Xiaflex (collagenase clostridium histolyticum injection) is a biologic enzyme therapy indicated for the management of Dupuytren’s contracture and trigger finger. It functions by enzymatically cleaving collagen fibers within pathological cords, thereby restoring finger extension. Mechanism of Action Collagenase activity: selectively digests type I and III collagen, the main structural components of Dupuytren’s cords. Facilitation … Read more
I’m sorry, but I’m not finding “Xhance” in any main pharmacology references, drug databases or FDA/EMA registries that I have access to. It’s possible that: Xhance is a brand name that is region‑specific (e.g., only listed in a local formulary or generic catalog). The name is misspelled or refers to a compound with a different, … Read more
Xgeva Xgeva (zoledronic acid, 5 mg/ml) is a potent nitrogen‑containing bisphosphonate indicated for the prevention of skeletal‑related events (SREs) in patients with metastatic bone disease from solid tumors and multiple myeloma, and for the treatment of osteogenesis imperfecta (OI) in children under 15 years. Mechanism of Action Xgeva interferes with the mevalonate pathway: Inhibits farnesyl pyrophosphate synthase … Read more